What are the Essential Elements to Enable Patient Participation in Medical Decision Making? by Fraenkel, Liana & McGraw, Sarah
What are the Essential Elements to Enable Patient Participation
in Medical Decision Making?
Liana Fraenkel, MD, MPH
1,2 and Sarah McGraw, PhD
3
1VA Connecticut Healthcare System, West Haven, CT 06516, USA;
2Yale University School of Medicine, New Haven, CT 06520, USA;
3New
England Research Institutes, Watertown, MA 02472, USA.
BACKGROUND: Patient participation in shared deci-
sion making (SDM) results in increased patient knowl-
edge, adherence, and improved outcomes. Despite the
benefits of the SDM model, many patients do not attain
the level of participation they desire.
OBJECTIVE: To gain a more complete understanding of
the essential elements, or the prerequisites, critical to
active patient participation in medical decision making
from the patient’s perspective.
DESIGN: Qualitative study.
SETTING: Individual, in-depth patient interviews were
conducted until thematic saturation was reached. Two
analysts independently read the transcripts and jointly
developed a list of codes.
PATIENTS: Twenty-six consecutive subjects drawn
from community dwelling subjects undergoing bone
density measurements.
MEASUREMENTS: Respondents’ experiences and
beliefs related to patient participation in SDM.
RESULTS: Five elements were repeatedly described by
respondents as being essential to enable patient partic-
ipation in medical decision making: (1) patient knowl-
edge, (2) explicit encouragement of patient participation
by physicians, (3) appreciation of the patient’s respon-
sibility/rights to play an active role in decision making,
(4) awareness of choice, and (5) time.
LIMITATIONS: The generalizability of the results is
limited by the homogeneity of the study sample.
CONCLUSIONS: Our findings have important clinical
implications and suggest that several needs must be
met before patients can become active participants in
decisions related to their health care. These needs
include ensuring that patients (1) appreciate that there
is uncertainty in medicine and “buy in” to the impor-
tance of active patient participation in decisions related
to their health care, (2) understand the trade-offs related
to available options, and (3) have the opportunity to
discuss these options with their physician to arrive at a
decision concordant with their values.
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INTRODUCTION
Shared decision making (SDM), where patients play an active
role in decisions related to their health care, is being increas-
ingly thought of as the model of choice for complex medical
decisions involving more than 1 rational treatment option.
1
This is especially true for value sensitive decisions, such as
treatment for breast and prostate cancer or screening for colon
cancer.
1,2 Patient participation in medical decision making
may result in increased patient knowledge, satisfaction,
adherence with treatment, and improved outcomes.
3–8 Fur-
thermore, interactive discussions between physicians and
patients about possible options improve patient satisfaction
with provider care even among patients preferring a more
passive role in decision making.
9
Despite the benefits of the SDM model, not all patients prefer
an active role in decision making. Nonetheless, among patients
who do prefer an active or collaborative role, many do not attain
the level of participation they desire. Studies have shown that
less than half of patients achieve their preferred role in clinical
practice
10–13 with many acquiescing to a more passive role than
desired.
10,14,15 Although investigators have described the pre-
dictors of patient participation in SDM.
16–18 less is known
regarding why patients fail to participate at their desired level.
We conducted this study to gain a more complete under-
standing of the essential elements, or the prerequisites, critical
to active patient participation in medical decision making,
from the patients’ perspective. Identification of these factors is
needed before methods can be developed to promote and
facilitate SDM in clinical practice for patients who prefer to
be active participants. In contrast to most previous studies, we
allowed patients to discuss situations in which they perceived
an important decision had to be made, and did not query
patients on specific scenarios. We chose qualitative methods to
elicit the patient’s perspective because of its potential to clarify
complex issues and to identify new concepts not previously
addressed in the literature.
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614METHODS
Participants
Participants were drawn from a larger study examining patient
treatment preferences for osteoporosis.
19 The sampling frame
for the larger parent study was men (over the age of 65) and
postmenopausal women who had recently (within 2 weeks)
undergone bone densitometry from 6 centers in the greater
New Haven, Connecticut area. Subjects for this qualitative
study were drawn consecutively from the group of patients
whose bone densitometry measures were too high to make
them eligible to participate in the parent study. We attempted
to reach 44 individuals to participate in this study. Of these, 12
individuals could not be reached after 3 attempts by phone,
and 6 refused to participate. Twenty-six (59%) agreed to be
interviewed for this study. Other eligibility criteria included the
ability to speak and understand English. All participants gave
informed consent and the Yale University Institutional Review
Boards approved the protocol.
Interviews
Individual face-to-face interviews were chosen over focus
groups for this study because interviews allow for more in-
depth exploration of each respondent’s experiences and
thoughts. Using a semistructured discussion guide, the inter-
views followed a funnel structure, progressing from broader
and open-ended questions to more structured questions with
specific probes to clarify issues as needed.
20 A formal discus-
sion guide was developed based on pilot interviews with 2
participants. The guide included 14 open-ended questions
on participants’ experiences with medical decision making
(see Appendix). Unless participants had covered a topic without
being prompted, all participants were asked each of the 14
questions. Further prompts were used as required to encour-
age discussion with patients tending to answer with brief
responses.
Interviews were conducted until thematic saturation was
reached. The interviews were audiotaped and transcribed by a
professional transcription service. Study investigators read
each transcript as it became available creating a preliminary
list of themes. Data collection ended when no new themes or
ideas arose during an interview. Each interview ran for up to
90 min and was conducted by the same Ph.D. level senior
research scientist (SMCG) with extensive experience conduct-
ing qualitative interviews. Demographic data (age, gender,
race, highest level of education attained, marital and employ-
ment status) were collected at the beginning of each interview
using a self-administered paper and pencil questionnaire. All
questions offered a defined set of responses except for age.
Analysis
The analysts (SMCG and LF) independently read all of the
transcripts and developed an initial list of codes.
21 The in-
dependent coding was subsequently jointly reviewed by the
analysts. Transcripts were then reread to confirm the list of
codes and create subheadings.
22 The constant comparative
method approach was employed to ensure that the analysts
defined and applied the codes in a consistent manner across
all transcripts. Using 2 readers ensured that a broader range
of codes was identified. QSR*NUDIST (Sage Publications
Software, Thousand Oaks, California) was used to identify
and sort the relevant text across the transcripts for each
code.
23 All codes related to enabling active patient participa-
tion in decision making were retained and are presented in this
paper. Demographic data were summarized using descriptive
statistics (SAS Software, version 8.0, SAS Institute Inc., Cary,
North Carolina).
RESULTS
Participant Characteristics
A total of 25 women and 1 man were interviewed between April
2004 and June 2005. The mean age of the participants was 61
(range 49 to 76). All were Caucasian, 69% were married, 50%
had a graduate degree, and 23% were retired.
Main Themes
Five elements were repeatedly described by respondents as
being essential to enable patient participation in medical
decision making: (1) patient knowledge, (2) explicit encourage-
ment of patient participation by physicians, (3) appreciation of
the patient’s responsibility/rights to play an active role in
decision making, (4) awareness of choice, and (5) time. As
illustrated in the following paragraphs, these domains overlap,
but each emphasizes distinct goals that must be fulfilled to
enable patient participation in decision making.
Patient Knowledge. Participants repeatedly emphasized that
being adequately informed was absolutely essential to be able
to participate in the decision-making process with their
physicians:
You only spend so much time in a doctor’s office, and if you don’t
understand something it’s always good to either go to the library
and get some more information or talk to another doctor to get
another opinion so that you know as much about it as you can
before you make a decision. (Interview #6)
If you don’t know, then how do you make the choice. You can’t
because you don’t have the information. (Interview #7)
For example, 1 respondent commented that she saw her role
as being very limited in making decisions about the treatment of
her breast cancer because she was not adequately informed.
They asked me how do you like this or what do you think of that,
and I would usually say—I will take your advice—because the
average lay person knows nothing you know. (Interview #19)
Several participants pointed out that they had considerable
difficulty dealing with the amount and complexity of the
information they received:
Because there’s so much information to take in that I think it
can be hard to process it. (Interview #16)
Doctors talk so far over their heads. They’ve got to have someone
... that can interpret what the doctor is saying, and that can ask
questions. (Interview #8)
(Someone needs to point out) here’s what you really need to sit
up and pay attention (to) and here are the factors you ought to
ask about, so that you have a little more guidance about what is
important and what isn’t important. (Interview #23)
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Beyond providing and clarifying complex information,
participants in this study felt that physicians should facilitate
patient participation in decision making by enabling patients
to ask questions:
You don’t want to go see a doctor that says this is what you have
to have done, who doesn’t give you a chance to ask questions.
(Interview #24)
I think that’s where the relationship with a doctor comes in. I feel
like I can question things that my doctor says, if I don’t
understand I can ask him about it so that I can make an
informed decision. (Interview #16)
Others emphasized the patient–physician relationship as
being an important partnership in which to evaluate choices:
I think that I’m actually very happy with being able to get most of
my medical care from somebody that I feel I have a good
relationship with, is knowledgeable, can share with me how
other patients have done and really help me make informed
decisions. (Interview #16)
There has to be a back and forth conversation because it’s your
life. The more comfortable you feel, the more open you’ll be to
talking about other options. (Interview #6)
Several subjects also discussed the importance of physi-
cians’ attitudes in enabling patient participation. For example,
the following quotes illustrate that some patients may avoid
active participation so as not to annoy their physician:
Some people fear that they are going to antagonize the person
that is taking care of them and that somehow that is going to
impact their care. (Interview # 7)
Well if you’re at odds with what the doctor prescribed, you know
they won’t like it. (Interview # 19)
Appreciation of the Patient’s Responsibility/Rights to Play an
Active Role in Decision Making. Many of the participants felt
that patients had a responsibility to actively participate in
decisions involving their health:
A patient has to be involved. It’s their body and ultimately they
are the ones who are going to be carrying out whatever decision’s
been made because they’re the ones living with it day to day.
(Interview #20)
It’s very important for the doctor to make it clear what those side
effects are and what the risks are. But it’s also important for the
patient to make sure they understand. (Interview #18)
You really have the responsibility of educating yourself as much as
possible. (Interview #9)
Several patients described an inverse association between
level of trust in their physicians and the importance of active
patient participation.
If she doesn’t feel secure with what the doctor says, then she should
ask a lot of questions, but I just feel that I have good doctors and I
take their advice. (Interview #19)
If you’ve gone to a doctor long enough, if he has a good reputation
that would lean me more to take his decision as the right decision.
(Interview #24)
Some respondents thought that patients’ rights to partici-
pate were related to payment for services:
It’s my body; I should have the right to make decisions on the
treatment. (This) might annoy the doctor, but you’re paying
them. (Interview #2)
Similarly, another respondent described feeling as though
she and her family did not have the right to participate in
decisions about treatment for her father because they were not
paying for the medical bills:
We felt like we were helpless in the decision making. One,
because he was in a situation where we weren’t paying any
medical because of where he was, so they made you feel like you
didn’t have any say in the decision. (Interview #1)
Awareness of Choice. To participate in decision making,
patients must first acknowledge that there is uncertainty in
medicine. In this study, patients’ perception of choice appeared
to be related to context. Patients realized the importance of
patient participation for decisions which were clearly value-
based. For example:
Like if I was in a breast cancer situation and we’re dealing with
whether it’s a mastectomy or a lumpectomy and this is purely
personal...I would never leave the decision to the doctor.
(Interview #1)
In contrast, in other situations patients failed to perceive a
“choice” and therefore deferred to their physicians as illustrat-
ed by the following quotes:
I don’t think I had a choice. I thought I had to do what the doctor
wanted me to do. (Interview #5)
I think we were young and scared and I think if we were a little
older and wiser we might have gotten other opinions. It’s
whatever they told us, that’s what we believed. (Interview #1)
I just figured I didn’t have a choice. (Interview #3)
The preceding quotes all refer to clinical contexts with more
than 1 available treatment option in which the SDM model
would have been appropriate.
Time. The lack of time spent with patients during medical
encounters is frequently cited as a barrier to providing effective
healthcare. In this study, at the end of the interview, when
specifically prompted to describe additional barriers to
enabling active patient participation in medical decision
making, “time” was the only factor discussed by participants.
Limited time was seen as a barrier to becoming informed and
as a barrier to processing information to derive preferences:
A lot of them don’t explain things—they don’t have the time or
they don’t take the time. (Interview #12)
It just doesn’t feel like there’s ever room in the system anymore
for real dialogue. In other words, that’s what gets in the way.
Time...Time sadly. (Interview #5)
Participants also felt that lack of time limits the extent to
which physicians can help their patients process information.
They (patients) bring things in from the Internet, and then time is
taken up wading through a lot of stuff, which may not even be of
importance. So...when there is a little bit of time it is confused by
all of the outside information that patients have. (Interview #11)
Toovercomethisbarrier,1respondentsuggestedthatpatients
might consider rescheduling their appointment to ensure that
their physician had enough time to spend with them:
Calling ahead and saying, I have a lot of questions today and I
might need a little more time with the doctor. Is this the best
time or should I reschedule for another day? (Interview #18)
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In this study, participants were able to describe several factors
that they considered essential in order for patients to be able to
participate in medical decision making. These fundamental
issues share overlapping features, but each highlights specific
processes which need to be addressed in order to promote
SDM in clinical practice.
Participants repeatedly emphasized the importance of being
adequately informed to participate in decision making. They
noted that if they weren’t informed, they had little choice but to
defer to their physician. They also stressed that merely
obtaining information was necessary, but not sufficient, to
become an informed patient. To achieve the latter, resources
are needed to help patients process the large amount of
complex, and at times conflicting, information they receive
from diverse sources.
Although one might expect that trust in physician would be
positively associated with active patient participation, subjects
in this study felt that their participation was most important
when they had less trust in their physician. This finding is
consistent with those of Kraetschmer et al.
24 who also found
an inverse association between preferred role in decision
making and trust and suggests that patients may fail to
recognize the value of their input in situations where they
have complete trust in their physician. Alternatively, patients
having high levels of trust may believe that their physicians
understand their values and know what’s best for them.
In 2004, Robert McNutt published a commentary de-
scribing patients’ responsibility to participate in decision
making regardless of their preferences.
25 This view was
shared by some of the participants in this study who felt
that it was the patient’s responsibility to become informed
and to participate in decisions affecting their health care. It
i si n t e r e s t i n gt on o t et h a ts o m ef e l tt h a tt h e yh a dt h er i g h t
to participate because they were “paying” patients. This
latter view, in conjunction with the finding that some
patients worried that their participation might annoy their
physicians, emphasizes the need for healthcare profes-
sionals to explicitly encourage patient input.
Some participants did not even realize that there were
choices to consider. Unless patients understand the con-
cept of uncertainty in medicine and the possibility of there
being more than 1 rational option, there is no reason for
patients to want to participate in decision making. When
specifically prompted to discuss obstacles to SDM in
clinical practice, almost all participants described the lack
of time as being a barrier. As high quality decision-making
processes require adequate time, and time constraints in
medicine are pervasive and unlikely to change, further
efforts, such as the more widespread use of decision aids,
26
a r en e e d e dt oi n f o r mp a t i e n t so u t s i d eo ft h ep a t i e n t –
physician relationship.
L i m i t a t i o n so ft h i ss t u d yl i ep r i m a r i l yi nt h eg e n e r a l i z -
ability of the results. Given the homogeneity of the study
population, future studies are needed to replicate and
expand our results. Although we conducted interviews until
thematic saturation was reached, i.e., until no new themes
arose, our sample was composed primarily of well-educated
postmenopausal women, thereby limiting the generalizabil-
ity of the themes discussed in this group. However, this
demographic group is among those most likely to want to
actively participate in SDM, therefore the factors discussed
in this study are likely relevant for patients desiring an
active role in SDM. Because men and women have different
attitudes towards healthcare, future studies should explore
whether men perceive supplementary or dissimilar themes
as being essential to enable active patient participation in
decision making. In addition, it is important to expand
such studies to include patients with more varied educa-
tional backgrounds because less well-educated patients
would likely identify additional needs to ensure a level of
participation commensurate with their preferred roles.
Despite these limitations, our findings have important
clinical implications and suggest that several needs must be
met before patients can become active participants in decisions
related to their health care. These needs include ensuring that
patients (1) appreciate that there is uncertainty in medicine
and buy in to the importance of active patient participation,
(2) understand the trade-offs related to available options, and
(3) have the opportunity to discuss these options with their
physician to arrive at a decision concordant with their values.
The common features underlying all these factors are the need
for patients to be adequately informed and for physicians to
give patients the opportunity to participate.
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APPENDIX
Discussion Guide
Attitudes Towards Shared Decision-making Study. The purpose
of this study is to understand communication between
patients and their doctors around treatment decisions. We
are interested in understanding how patients and their doctors
make decisions about treatment for an illness or a medical
condition. The information gathered through this study will be
used to develop strategies to help patient and doctors
communicate more effectively.
I will be asking you 14 questions. They are all open-ended
questions and there are no right or wrong answers. The first 6
questions are about your own experiences in making decisions
aboutmedicalcare.Theyarenotnecessarilyspecifictoosteoporosis.
1. To begin, I am going to ask you to think back to a time
when an important decision had to be made about your
617 Fraenkel and McGraw: Essential Elements in Patient Participation JGIMtreatment for an illness or a medical condition. [NOTE: Do
not include small decisions, such as having a blood test.]
IF PARTICIPANT CANNOT THINK OF A DECISION FOR
THEMSELVES, ASK ABOUT A PARENT, CHILD, OR SOME
OTHER PERSON THEY CARE FOR.
Please tell me about that situation.
Tell me very briefly about the illness or condition.
Also, just briefly, how did you find out about this illness or
condition?
What was the decision that had to be made about treating
this condition?
How was the decision made?
What was your role in the decision-making process?
What were you told to do?
What did do about it?
Who did you talk to about this decision?
Why did you choose to do this?
Who helped you to make this decision?
What information did you gather about making this
decision?
How did you get this information?
Are there other things you have considered doing?
2. Thinking back about this decision and other decisions
related to your health care, to what extent do you feel that
you have shared in the decision making with your doctor(s)?
Why? PROBE: To what extent do you feel you have had a
role in, or participated in the decision making?
3. Thinking back over times when you faced a decision about
medical care, was there ever a time when you wished you
had a bigger role in the decision-making process? PROBE:
Why did you wish you had a larger role?
4. Now, thinking back about times when you faced a decision
about medical care, was there ever an instance when you
wished you were asked to make fewer decisions or have less
of a role in the decision-making process? PROBE: Why?
5. Have you ever disagreed with your doctor about a
treatment plan that was suggested to you? PROBE: How
did you handle this disagreement?
6. Have you ever been told by a doctor to try a treatment
option that was impractical for you? How did you respond
to this? PROBE: Has a doctor ever disagreed with you
about something you wanted to try?
The next 4 questions are about the value or importance you
place on elements of the decision-making process.
7. In a situation where there are choices about treatment,
how important is the physician’s recommendation to you
in making a decision?
8. How important is it for the patient and doctor to share a
similar outlook, such as values about health or use of
medicine? Why? PROBE: Think about a situation where
there are 2 medicines approved for an illness, medicine A
and medicine B. What would you do if you wanted to take
medicine A but the doctor recommended medicine B?
9. How important do you think it is for your doctor to have a
clear understanding of what issues are most important to
you when deciding which treatment to take?
10. How important is it that a physician explains clearly the
financial costs of a course of treatment? Why?
The next set of questions covers your beliefs and attitudes
about patient involvement in treatment decisions.
11. I will begin this set by asking you to talk about the pros
and cons of having a patient participate in the decision-
making process. What are your thoughts about having a
patient be part of the decision? Why? PROBE: What is
the best way to make a decision about how to treat an
illness or a medical condition? Why? PROBE: What are
the pros and cons of each approach? Why?
12. Every treatment has a chance of helping, as well as a
chanceof causing side effects.Who shoulddecide whether
the treatment is worth the risk? PROBE: Who should
decide what side effects the patient should put up with?
13. In general, do you think there any barriers in our health
care system which make it difficult for patients to
participate in their health care? Why?
14. What do you think could be done to improve the
decision-making process for you?
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